Siemens Healthineers in collaboration with SelectScience, hosted a webinar aimed to demystify HbA1c testing at the point of care and discuss the possible impacts of a COVID-19 diagnosis on people living with diabetes. Our esteemed panelists, Dr. Erna Lenters-Westra, Professor Emma English, and Professor Garry John led a vibrant discussion, sharing their insights on the subject of HbA1c POC testing.
The webinar is available on-demand and includes P.A.C.E. credits. In addition, the Webinar was featured in SelectScience’s Expert Insight series.
Dr. Erna Lenters Westra
Professor Garry John
Key learning objectives
- List the key benefits of HbA1c point-of-care testing.
- Identify the quality measures HbA1c instruments must adhere to throughout the product lifecycle.
- Identify possible long-term health implications of COVID-19 on those living with diabetes.
Who should attend?
Point-of-care coordinators, nurses, diabetologists, physicians, endocrinologists, clinicians, patients, providers, and researchers.